{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:46:35Z","timestamp":1747161995198,"version":"3.40.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005363","name":"University of Buenos Aires","doi-asserted-by":"publisher","award":["20020090200299"],"award-info":[{"award-number":["20020090200299"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2012-0422"],"award-info":[{"award-number":["PICT-2012-0422"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ijantimicag.2015.04.011","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T08:35:35Z","timestamp":1433579735000},"page":"219-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Previous failure of interferon-based therapy does not alter the frequency of HCV NS3 protease or NS5B polymerase inhibitor resistance-associated variants: longitudinal analysis in HCV\/HIV co-infected patients"],"prefix":"10.1016","volume":"46","author":[{"given":"Mariano M.","family":"Sede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia L.","family":"Laufer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5110-8773","authenticated-orcid":false,"given":"Jorge","family":"Quarleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.02.004","article-title":"Towards hepatitis C eradication from the HIV-infected population","volume":"105","author":"Barreiro","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0085","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/ajg.2013.205","article-title":"A translational study of resistance emergence using sequential direct-acting antiviral agents for hepatitis C using ultra-deep sequencing","volume":"108","author":"Abe","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0090","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1128\/AAC.03466-14","article-title":"Hepatitis C virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV\/HIV coinfection","volume":"58","author":"Jabara","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.antiviral.2014.05.015","article-title":"Update on hepatitis C virus resistance to direct-acting antiviral agents","volume":"108","author":"Poveda","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0100","doi-asserted-by":"crossref","first-page":"30ra2","DOI":"10.1126\/scitranslmed.3000544","article-title":"Rapid emergence of protease inhibitor resistance in hepatitis C virus","volume":"2","author":"Rong","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0105","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1053\/j.gastro.2011.02.060","article-title":"CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins","volume":"140","author":"Ruhl","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/1521-4141(200201)32:1<144::AID-IMMU144>3.0.CO;2-X","article-title":"Effect of interferon-\u03b1 therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals","volume":"32","author":"Vertuani","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"EASL clinical practice guidelines: management of hepatitis C virus infection","volume":"55","author":"European Association for the Study of the Liver","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0120","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/bioinformatics\/btr026","article-title":"Quality control and preprocessing of metagenomic datasets","volume":"27","author":"Schmieder","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0125","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1073\/pnas.76.10.5269","article-title":"Mathematical model for studying genetic variation in terms of restriction endonucleases","volume":"76","author":"Nei","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/genetics\/123.3.585","article-title":"Statistical method for testing the neutral mutation hypothesis by DNA polymorphism","volume":"123","author":"Tajima","year":"1989","journal-title":"Genetics"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0135","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/bioinformatics\/btp187","article-title":"DnaSP v5: a software for comprehensive analysis of DNA polymorphism data","volume":"25","author":"Librado","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0140","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/hep.26641","article-title":"Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-na\u00efve genotype 1 hepatitis C: the randomized PILLAR study","volume":"58","author":"Fried","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0145","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.02495-13","article-title":"Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C virus NS5B polymerase","volume":"58","author":"Lemm","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.04.011_bib0150","unstructured":"American Association for the Study of Liver Diseases\/Infectious Diseases Society of America\/International Antiviral Society\u2013USA (AASLD\/IDSA\/IAS-USA). Recommendation for testing, managing and treating hepatitis C. http:\/\/hcvguidelines.org. Last modified date 25 September 2014."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915001880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915001880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T17:27:08Z","timestamp":1652290028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915001880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0924857915001880"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.04.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Previous failure of interferon-based therapy does not alter the frequency of HCV NS3 protease or NS5B polymerase inhibitor resistance-associated variants: longitudinal analysis in HCV\/HIV co-infected patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}